Back

Evidence for ANTXR2 as a therapeutic target on systemic-to-pulmonary shunt induced pulmonary arterial hypertension

3 September 2019 (15:45 - 16:35)
Organised by:
Congress Presentation Part of: Basic mechanisms of pulmonary disease Pulmonary Hypertension ESC Premium Access ESC Congress 2019

About the speaker

Photo
Miss Xiaoyan Liu

Beijing Chaoyang Hospital affiliated to Capital Medical University, Beijing (China)

6 More presentations in this session

Presentation thumbnail
Cardiovascular coupling and elastic properties of pulmonary artery in different phenotypes of patients with pulmonary hypertension
Doctor I. Lyapina (Kemerovo, RU)
Abstract Slides
Presentation thumbnail
Inhibin Beta-A is a novel gene involved in the development of pulmonary arterial hypertension through inhibiting BMPRII-signaling in endothelial cells
Doctor G. Ryanto (Kobe, JP)
Abstract Slides
Presentation thumbnail
Poor outcomes in pulmonary arterial hypertension as a member of RNF213-associated vascular diseases
Doctor T. Hiraide (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Deficiency in milk fat globule-epidermal growth factor 8 delays thrombus resolution
Doctor T. Hofbauer (Vienna, AT)
Abstract
Presentation thumbnail
NKX2-5 contributes to EndoMT and endothelial dysfunction in pulmonary arterial hypertension
Mr J. Santos Cade (London, GB)
Abstract Slides

Access the full session

Session thumbnail
Basic mechanisms of pulmonary disease

The Event

Event poster

ESC Congress 2019

3 September 2019 15:45 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources